Sponsor or institution
Clinical trials and research at Shanghai Tong Ren Hospital
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Shanghai Tong Ren Hospital that are recruiting, in China. By phase: Phase 2 (2), Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Posterosuperior Bundle Pacing to Reduce Atrial Fibrillation in Sinus Node Dysfunction | — | Anqing, Anhui and 9 other locations | Recruiting | Jun 12, 2026 |
| Immediate effects of different atrial pacing sites on P-wave characteristics | — | Zunyi, Guizhou and 1 other locations | Recruiting | May 22, 2026 |
| Adaptive treatment for acute myeloid leukemia based on early results | Phase 2 | Shanghai and 3 other locations | Recruiting | Feb 21, 2023 |
| Combination treatment for untreated acute myeloid leukemia | Phase 2 | Changzhou and 18 other locations | Recruiting | Feb 21, 2023 |
| Early treatment with PCSK9 inhibitors after heart attack | Phase 4 | Shanghai, Shanghai Municipality and 4 other locations | Recruiting | Mar 23, 2022 |
| Using PCSK9 inhibitors to improve heart recovery after a heart attack | Phase 4 | Shanghai, Shanghai Municipality and 1 other locations | Recruiting | Jan 29, 2021 |
All recruiting trials (6)
-
Posterosuperior Bundle Pacing to Reduce Atrial Fibrillation in Sinus Node Dysfunction
This study tests whether pacing the heart at the posterosuperior bundle reduces atrial fibrillation compared with traditional right atrial appendage pacing in adults needing a pacemaker.
-
Immediate effects of different atrial pacing sites on P-wave characteristics
This study tests whether pacing the atrium from different sites during pacemaker implantation changes the P-wave on ECG to better reflect natural atrial activation.
-
Adaptive treatment for acute myeloid leukemia based on early results
This study is testing a new treatment plan for people with untreated acute myeloid leukemia to see if adding a drug called selinexor helps those who still have cancer after two weeks of initial therapy.
-
Combination treatment for untreated acute myeloid leukemia
This study is testing a new combination of three medications to see if they can help people with untreated acute myeloid leukemia go into remission.
-
Early treatment with PCSK9 inhibitors after heart attack
This study is testing if giving a new heart medication called alirocumab right after a heart attack can help patients recover better than standard treatment.
-
Using PCSK9 inhibitors to improve heart recovery after a heart attack
This study is testing if giving a new heart medication called Alirocumab right after a heart attack can help patients recover better and prevent further heart damage.
Quick answers
How many clinical trials run by Shanghai Tong Ren Hospital are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.